Results 11 to 20 of about 22,549 (256)

Lek med problemer [PDF]

open access: yesNordisk Barnehageforskning, 2023
Med gjeninnføring av lek i skolens læreplan er det behov for å vurdere hvordan lek har vært knyttet til matematikk i barnehagen. Vi bruker en modell som kobler sammen barns lek med det å stille og å løse problemer, til å analysere barnehagebarns ...
Trude Fosse, Troels Lange, Tamsin Meaney
doaj   +2 more sources

Dramatisk lek [PDF]

open access: yes, 2021
Etter å ha gått fordypningen innenfor de estetiske fagene har jeg blitt oppmerksom på hvordan barna bruker leken til å utforske det estetiske. Nærmere bestemt virkemidlene som ligger til grunn i barns dramatiske lek og uterommet som tilbyr andre impulser til leken.
Holmeng, Bodil Renna
openaire   +2 more sources

Barns behov for lek [PDF]

open access: yes, 2022
Målet med denne mastergradsavhandlingen var å undersøke lærernes syn på lek, og se dette inn mot hvordan barns behov for lek blir ivaretatt når de begynner på skolen. Valget falt på en kvalitativ forskningsstrategi. Jeg samlet inn data, ved å gjennomføre
Larsen, Ruth
core   +1 more source

Harvesting a knowledge commons: collective action, transparency, and innovation at the Portland Fish Exchange

open access: yesInternational Journal of the Commons, 2014
While localist visions of alternative food systems advocate for the expansion of local ecological knowledge through more proximate producer-consumer relationships, globalized seafood supply-demand chains persist.
Jennifer F. Brewer
doaj   +1 more source

On the Stability and Degradation Pathways of Venetoclax under Stress Conditions

open access: yesPharmaceutics, 2020
Venetoclax is an orally bioavailable, B-cell lymphoma-2 (BCL-2) selective inhibitor, used for the treatment of various types of blood cancers, such as chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).
Nina Žigart   +3 more
doaj   +1 more source

LEKI CYFROWE. PROBLEMATYKA PRAWNA

open access: yesZeszyty Prawnicze, 2016
Digital Medicines. Legal Aspects Summary The subject of this article is the legal examination of digital medicines, a new type of medicinal product. The basis for the author’s remarks is the procedure launched by the US FDA (US Federal Food and Drug ...
Zbigniew Więckowski
doaj   +1 more source

Biopharmaceutical classification of desloratadine – not all drugs are classified the easy way

open access: yesActa Pharmaceutica, 2020
The biopharmaceutical classification of drugs was designed as a basis for bio-waivers – a mechanism with the double ethical benefit of delivering new drug formulations to the market with less human testing and lower cost.
Berginc Katja   +4 more
doaj   +1 more source

Optimization of UPLC method for simultaneous determination of rosuvastatin and rosuvastatin degradation products

open access: yesActa Chimica Slovenica, 2017
An ultra-performance liquid chromatographic method for simultaneous determination of rosuvastatin and rosuvastatin degradation products was developed and optimized by using fractional factorial experimental design.
Jure Zakrajšek   +3 more
doaj   +2 more sources

Female preference and predation risk models can explain the maintenance of a fallow deer (Dama dama) lek and its 'handy' location.

open access: yesPLoS ONE, 2014
We tested the predictions of three models (female preference; hotspot; predator avoidance) on lek formation in the fallow deer population of San Rossore, Tuscany.
Marco Apollonio   +3 more
doaj   +1 more source

Combining Artificial Intelligence and Local Ecological Knowledge to Document the Largest Ever-Counted Cape Buffalo Mega-Herd. [PDF]

open access: yesEcol Evol
Large aggregations of wild mammals are declining worldwide, yet opportunistic wildlife videos from non‐scientists can capture rare or ecologically significant events valuable to conservation. Using drone footage of a Cape buffalo megaherd in northern Botswana, we applied automated detection to estimate a total of about 4100 individuals, the largest ...
Bennitt E   +5 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy